InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Explore the detailed record of transactions filed by COHEN RON, Chief Executive Officer. Director active across 1 companies, notably Acorda Therapeutics INC. Aggregated, 3 filings have been recorded. Total volume traded: €4k. The latest transaction was filed on 17 March 2022 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations3 total
€3,5332,289 shares@ €1.543610.8% of flow
Common Stock
SEC:0001209191-22-020260:0·
€14,5313,940 shares@ €3.688100.0% of flow
Common Stock
SEC:0001209191-21-055099·
€14,5313,940 shares@ €3.68844.6% of flow
Common Stock
SEC:0001209191-21-055099:0·
3 of 3 declarations
About COHEN RON
Ron Cohen is the President and CEO of ACORDA THERAPEUTICS INC. He leads the company by overseeing all operations and defining the overall strategy. His role is essential in ensuring the company's growth and innovation in the biotechnology sector. Through his leadership, he guides the team toward achieving business objectives while ensuring regulatory compliance and stakeholder satisfaction.
